ClinicalMetric / Countries / Czech Republic / multiple myeloma
← 🇨🇿 Czech Republic Trials
🇨🇿 Czech Republic Country × Condition

multiple myeloma Clinical Trials in Czech Republic

Active clinical trials for multiple myeloma with research sites in Czech Republic. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 Phases: Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇨🇿 Czech Republic

Active Trials in Czech Republic (2)

NCT06237803
Recruiting

European Myeloma Network (EMN) Sample Project

Enrollment
6,000 pts
Country
🇨🇿 Czech Republic
European Myeloma Network B.V.
View Trial →
NCT06932562 Phase 3
Recruiting

A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

Enrollment
1,000 pts
Country
🇨🇿 Czech Republic
European Myeloma Network B.V.
View Trial →

Frequently Asked Questions

How many multiple myeloma clinical trials are active in Czech Republic?
There are currently 2 active clinical trials for multiple myeloma with sites in Czech Republic, of which 2 are actively recruiting patients.
How can I join a multiple myeloma clinical trial in Czech Republic?
To join a multiple myeloma clinical trial in Czech Republic, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Czech Republic directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are multiple myeloma trials in Czech Republic?
Active multiple myeloma trials in Czech Republic span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Czech Republic Trials → Global multiple myeloma Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology